Precision Medicine for Aging-Related Diseases
A new approach to understanding and combating aging-related disease
Teal is a biotechnology company developing platform technology focused on aging-related diseases. Our proprietary, multi-omics-based platform uniquely unravels the complexities of aging and disease, and our drug discovery programs aim to find precision medicines for aging-related diseases of the central nervous and immune systems.
Our mission is to reshape healthcare by developing new approaches to treating age-related diseases. Through a novel understanding of aging, enabled by advanced proteomics, genomics, and artificial intelligence, we aim to accelerate the development of novel therapeutics that will enable precision medicine aimed at preventing age-related diseases.
Our Science
Teal’s technology builds on over 25 years of academic research conducted in Stanford University's Wyss-Coray lab. The lab has focused in on brain aging and neurodegeneration with a specific interest in age-related cognitive decline and Alzheimer’s disease. From this work, it was discovered that circulating blood factors can modulate brain structure and function and factors from young organisms can rejuvenate old brains.
Teal's science was built on the belief that a better understanding of aging biology will ultimately lead to insights that will accelerate the identification of new approaches for treating aging and aging-related disease. Our work focuses on the use of human proteomics as a tool for understanding aging and identifying novel causal targets for aging-related disease.
Our Team
Our Advisors
Jarod Rutledge, PhD
Co-Founder
Ray
Tabibiazar, MD
Advisor
Hamilton
Oh
Co-Founder
Bharat
Tewarie, MD
Advisor
Benoit
Lehallier, PhD
Advisor
Mike
Aicher
Advisor
Dr. Jay
Wohlgemuth
Advisor